Rwanda recalls drugs manufactured in Kenya
The Rwanda Food Drugs Authority (RFDA) announces recall of drugs manufactured in Kikuyu, Kenya over discolouration in the Fluconazole.
The Rwanda Food Drugs Authority (RFDA) declared on Wednesday, January 3, that a medication made in Kikuyu, Kenya, was being recalled.
The RFDA announced in a statement that it was recalling batches of Fluconazole 200mg tablets that were brought into the nation from Kenya.
This came after the Authority had already notified the Kenyan producer about discoloration in the 200 mg Fluconazole tablets.
Four bulk batches of pink Fluconazole 200 mg tablets that were brought into the nation, according to RFDA, developed a white discoloration after a brief period of storage.
“Rwanda FDA instructs all importers, central medical stores, wholesalers, RMS branches, retailers, Public and Private Health Facilities to stop the distribution of the above-mentioned batches of fluconazole 200mg tablets and return them to their suppliers for proper management,” the recall statement read in part.
Additionally, importers and sellers of the medication were asked to notify the FDA within ten days of the recall date.
Rwandan authorities and health officials will ask the importers and suppliers how many 200 mg tablets of fluconazole were supplied.
State House responds after CJ Koome, LSK criticism of Ruto over Judiciary attack
Kenyan priest found dead hanging on tree after going missing in Venezuela
LSK Announces Nationwide Protests After Ruto’s Remarks
Woman, 62, wins right to harvest dead husband’s sperm to have surrogate baby
Azimio leaders reprimand Ruto over his attack on the Judiciary
Former Uhuru CS Najib Balala faces another arrest
This will allow the Rwandan government to determine the negative effects the medication has had on the country’s citizens.
The Health Ministry will also receive final stocks on hand and quantities returned from the importers and suppliers.
Meanwhile, the Kenyan Health Ministry had not stated whether the drug would be recalled from Kenyan hospitals and chemists.
There was also no report of the pink tablet displaying a white discolouration in the Kenyan market.
In February 2020, Rwanda banned Kenyan-made azithromycin dry suspension 200 mg/5ml (Zerocin) following what they termed multiple complaints from users.
Also read,
Raila slams Ruto on threats to the Judiciary
CJ Koome tells off Ruto over attacks on the Judiciary
14-year-old boy arrested for forcing other children to steal from their parents
HELB launches new loan of up to Ksh500,000 for a select category of students
Follow us